13:00
May 11

Cannabotech raised NIS 1.2 million in a public offering

11:30
May 10

Together achieved an export permission from Germany to UK

14:00
January 20

Panaxia reports the first export of cannabis tablets to France as part of the pilot in which it participates and is expected to last about two years. The tablets were delivered to France free of charge.

13:00
January 22

Togther reports that the Securities Authority has initiated administrative enforcement proceedings against it in respect of its previous reports from 2018 and 2019 regarding business relations with China.

Recent News

May 17, 2022

Revenue growth is expected to continue in the second quarter and throughout 2022 due to organic growth, acquisition of ‘Better’, and international expansion…

April 25, 2022

Cronos and Intercure have similar EV and revenue, but the profitability is very different …

April 7, 2022

The medical cannabis market in Israel is one of the fastest growing in the world. According to data published by the Israeli Medical Cannabis…

March 22, 2022

InterCure (NASDAQ: INCR) and Clever Leaves (NASDAQ: CLVR) today announced the execution of an exclusive multi-year cultivation, marketing and distribution agreement. Over the term…

InterCure Announces Partnership with Altman Health

The partnership will focus on the new CBD wellness market in Israel

intercure
Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp
Share on telegram
Share on email

Intercure today announced it has signed a definitive agreement (the “Agreement”) with Altman Health LP (“Altman Health”), the market leader with an unmatched shelf space of OTC and nutritional supplements in over 1700 points of sale, including all major pharmacies across Israel. The newly formed company will focus on the new Israeli CBD product market, following the Israeli Minister of Health’s announcement yesterday that CBD will be removed from the Dangerous Drugs Act.

In December 2020, InterCure established an exclusive strategic partnership with Charlotte’s Web. The partnership with Altman Health will register, manufacture, market and distribute CBD products in Israel, including Charlotte’s Web branded products. Positioned as the first-to-market, offering high quality branded CBD products in the territory – endorsed by the country’s two leading and trusted brands both in wellness and medical cannabis.

Altman Health was created in 2005 by the merger of two leading health product firms, Ta’am Teva and Altman. Altman Health offers a wide range of health and wellness products, including
nutritional supplements, homeopathic solutions and medicinal cosmetics. Altman Health’s products can be found across the country in over 1700 points of sale including pharmacies, health
food stores, as well as in the national health fund clinics. Additionally, Altman Health has a trained professional staff of medical representatives who are in regular contact with the Israeli medical
community. The firm also operates a service and training department of veteran professionals, including naturopaths, nutritionists, and dieticians, who provide a professional response to
customer inquiries.

Alexander Rabinovitch, CEO of InterCure said: “The strategic partnership with Altman Health is a natural connection between groundbreaking and market-leading companies. InterCure is leading the pharmaceutical grade medical cannabis revolution, which within two and a half years has become the most sold out of pocket prescription drug in Israel and together with Charlotte’s Web, the world’s leading CBD company, we are positioned to lead the CBD revolution as well. The partnership with Altman Health, the leading Israeli entity in nutritional supplements with the largest shelf space across Israel, is a significant step for InterCure and the Israeli public, who for the first time will be able to enjoy the highest quality and safest CBD products without the need for a doctor’s prescription.”

Eynat Usant Ravid, CEO of Altman Health said: “The partnership with InterCure is an integral part of Altman Health’s long-term strategic plans, and the development of a significant growth engine in the healthy lifestyle space. The partnership is a natural and correct move that unites the two partners’ exceptional professional capabilities. Altman Health has been leading the dietary
supplement market in Israel for over 50 years, and we are happy to expand our activities into the CBD space.”

Share your thoughts, add a comment

Your email address will not be published.